- Report
- June 2026
- 172 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 370 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 389 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 184 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 276 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 387 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 162 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 383 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 200 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 168 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 387 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 292 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- June 2026
- 528 Pages
Global
From €5254EUR$5,850USD£4,522GBP
- Report
- January 2026
- 197 Pages
Global
From €3184EUR$3,545USD£2,740GBP
€3538EUR$3,939USD£3,045GBP
- Report
- January 2026
- 185 Pages
Global
From €4042EUR$4,500USD£3,478GBP
- Report
- January 2026
- 191 Pages
Global
From €3184EUR$3,545USD£2,740GBP
€3538EUR$3,939USD£3,045GBP
- Report
- May 2026
- 188 Pages
Global
From €4042EUR$4,500USD£3,478GBP
- Report
- January 2026
- 185 Pages
Global
From €4042EUR$4,500USD£3,478GBP
- Report
- January 2026
- 180 Pages
Global
From €4042EUR$4,500USD£3,478GBP
- Report
- January 2026
- 180 Pages
Global
From €4042EUR$4,500USD£3,478GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more